US
Patent Prosecution
Patent Strategy & Management
| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Baker, Hunter | Intellectual Property | Patent Prosecution | Boston |
| Gates, Edward | Intellectual Property | Patent Prosecution, Patent Strategy & Management, General Patent Litigation | Boston |
| Lockhart, Helen | Intellectual Property | Patent Strategy & Management | Boston |
| Oyer, Tim | Intellectual Property | Patent Prosecution, Patent Strategy & Management | Boston |
| Trevisan, Maryanne | Intellectual Property | Patent Prosecution, Patent Strategy & Management | Boston |
| Twomey, Michael J | Intellectual Property | Hatch-Waxman Patent Litigation, Patent Prosecution, Patent Strategy & Management, General Patent Litigation | Boston |
| Waller, Patrick R H | Intellectual Property | Patent Prosecution, Patent Strategy & Management | Boston |
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Intellectual Property
Wolf Greenfield & Sacks
Boston-based IP boutique Wolf Greenfield & Sacks earns top ranking for its expertise in patent prosecution and strategy for life sciences clients. A client notes the firm is "excellent" and "very responsive," while a peer adds Wolf Greenfield is a "reliable heavyweight in patent prosecution." The firm is notable for its significant number of attorneys with advanced scientific degrees, showcased by its biotech group, which is made up of more than 80% PhD or MD holders.
Biotechnology group chair Helen Lockhart specializes in patent prosecution and portfolio development for a variety of clients, including universities and research institutions, startups and midsize companies. She is currently advising a biotech startup in patent portfolio strategy. Edward Gates, deemed a "brilliant attorney" by a peer, has extensive experience counseling clients in the pharmaceutical and biotechnology areas on licensing and patent matters. He is currently involved in contentious IPR matters for a client.
Maryanne Trevisan provides clients with deep prosecution expertise in a number of advanced scientific areas, including cell biology and cancer therapies. Firm managing partner Tim Oyer and biotech partner Patrick RH Waller currently advise Oxford Nanopore in patent portfolio strategy.
New to the stars list is Hunter Baker, chair of the pharmaceuticals practice group. He specializes in patent prosecution, strategic counseling and technology transactions. He was recently active for a number of academic clients in life sciences technology licensing.